Loading…
Sources of residuals after endoscopic transsphenoidal surgery for large and giant pituitary adenomas
Background Giant and large pituitary adenomas (PA) constitute a specific subset of PAs, with gross total resection (GTR) rates frequently not exceeding 50%. Both an anatomical inaccessibility and an inadequate tumor visualization are thought to play a role. This study analyzes risk factors for posto...
Saved in:
Published in: | Acta neurochirurgica 2020-10, Vol.162 (10), p.2341-2351 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c403t-8af1f32f03e364ae1089dcc9eaf126f533a52ed7fd61e8e970a6f7d84b1b3663 |
---|---|
cites | cdi_FETCH-LOGICAL-c403t-8af1f32f03e364ae1089dcc9eaf126f533a52ed7fd61e8e970a6f7d84b1b3663 |
container_end_page | 2351 |
container_issue | 10 |
container_start_page | 2341 |
container_title | Acta neurochirurgica |
container_volume | 162 |
creator | Peto, Ivo Abou-Al-Shaar, Hussam White, Timothy G. Abunimer, Abdullah M. Kwan, Kevin Zavadskiy, Gleb Wagner, Katherine Black, Karen Eisenberg, Mark Bruni, Margherita Dehdashti, Amir R. |
description | Background
Giant and large pituitary adenomas (PA) constitute a specific subset of PAs, with gross total resection (GTR) rates frequently not exceeding 50%. Both an anatomical inaccessibility and an inadequate tumor visualization are thought to play a role. This study analyzes risk factors for postoperative residuals after endoscopic transsphenoidal pituitary surgery for large and giant pituitary adenomas.
Methods
A retrospective analysis of patients with giant and large PA operated between 2015 and 2018 was performed.
Results
Forty patients (13 females, 27 males) were included in the analysis (30 large and 10 giant PAs). The mean MRI follow-up time was 5.9 ± 6.54 months. Overall, GTR was achieved in 29 patients (72.5%), subtotal resection in 9 (22.5%), and the inconclusive result was in 2 (5%). Unexpected residuals represented 7 (77.7%) of all 9 residual tumors. The most frequent intraoperative factor associated with unexpected residual tumors was improper identification of residual tumor due to obstruction of view in 2 (28.5%) cases and inability to distinguish normal tissue from tumor in the other two (28.5%). Sub-analysis based on tumor size revealed that with large PAs, GTR was achieved in 25 (83.3%), STR in 4 (13.3%), and inconclusive in 1 (3.3%) patient. In patients with giant PAs, GTR was achieved in 4 (40%), STR in 5 (50%), and inconclusive in 1 (10%). Analysis of preoperative factors showed a significant association of residual tumors with larger suprasellar AP distance (
p
= 0.041), retrosellar extension (
p
= 0.007), and higher Zurich Score (
p
= 0.029).
Conclusion
Large and giant PAs are challenging lesions with high subtotal resection rates. Suprasellar AP distance, retrosellar extension, and higher Zurich Score seem to be significant predictors of degree of resection in these tumors. Improving the intraoperative ability to distinguish tumor from a normal tissue might further decrease the number of unexpected residuals. |
doi_str_mv | 10.1007/s00701-020-04497-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2426535514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2522966417</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-8af1f32f03e364ae1089dcc9eaf126f533a52ed7fd61e8e970a6f7d84b1b3663</originalsourceid><addsrcrecordid>eNp9kctO3TAQhi0EAgq8QBfIEptuUsaXOMmyQvQiHamLsrd84jENyolTT7Lo2zNwoJVYsBmPPd_8tucX4qOCzwqguSYOoCrQUIG1XVOpA3EKndUVBzjkHLjstGtPxAeiB97pxppjcWJ0w7UWTkX8ldfSI8mcZEEa4hpGkiEtWCROMVOf56GXSwkT0fwbpzzEMEpayz2WvzLlIsfAuQxTlPdDmBY5D8s6LIGrITK_C3QujhLL4sXLeibuvt7e3XyvNj-__bj5sql6C2ap2pBUMjqBQeNsQAVtF_u-Qz7XLtXGhFpjbFJ0ClvsGgguNbG1W7U1zpkz8WkvO5f8Z0Va_G6gHscxTJhX8tpqV5u6VpbRqzfoA89h4sd5XWvdOWdV8y5lrTKtaw0wpfdUXzJRweTnMuz4_16BfzLK743ybJR_Nsorbrp8kV63O4z_Wl6dYcDsAeLSxMP-f_c7so9UKZ4-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2441386830</pqid></control><display><type>article</type><title>Sources of residuals after endoscopic transsphenoidal surgery for large and giant pituitary adenomas</title><source>Springer Nature</source><creator>Peto, Ivo ; Abou-Al-Shaar, Hussam ; White, Timothy G. ; Abunimer, Abdullah M. ; Kwan, Kevin ; Zavadskiy, Gleb ; Wagner, Katherine ; Black, Karen ; Eisenberg, Mark ; Bruni, Margherita ; Dehdashti, Amir R.</creator><creatorcontrib>Peto, Ivo ; Abou-Al-Shaar, Hussam ; White, Timothy G. ; Abunimer, Abdullah M. ; Kwan, Kevin ; Zavadskiy, Gleb ; Wagner, Katherine ; Black, Karen ; Eisenberg, Mark ; Bruni, Margherita ; Dehdashti, Amir R.</creatorcontrib><description>Background
Giant and large pituitary adenomas (PA) constitute a specific subset of PAs, with gross total resection (GTR) rates frequently not exceeding 50%. Both an anatomical inaccessibility and an inadequate tumor visualization are thought to play a role. This study analyzes risk factors for postoperative residuals after endoscopic transsphenoidal pituitary surgery for large and giant pituitary adenomas.
Methods
A retrospective analysis of patients with giant and large PA operated between 2015 and 2018 was performed.
Results
Forty patients (13 females, 27 males) were included in the analysis (30 large and 10 giant PAs). The mean MRI follow-up time was 5.9 ± 6.54 months. Overall, GTR was achieved in 29 patients (72.5%), subtotal resection in 9 (22.5%), and the inconclusive result was in 2 (5%). Unexpected residuals represented 7 (77.7%) of all 9 residual tumors. The most frequent intraoperative factor associated with unexpected residual tumors was improper identification of residual tumor due to obstruction of view in 2 (28.5%) cases and inability to distinguish normal tissue from tumor in the other two (28.5%). Sub-analysis based on tumor size revealed that with large PAs, GTR was achieved in 25 (83.3%), STR in 4 (13.3%), and inconclusive in 1 (3.3%) patient. In patients with giant PAs, GTR was achieved in 4 (40%), STR in 5 (50%), and inconclusive in 1 (10%). Analysis of preoperative factors showed a significant association of residual tumors with larger suprasellar AP distance (
p
= 0.041), retrosellar extension (
p
= 0.007), and higher Zurich Score (
p
= 0.029).
Conclusion
Large and giant PAs are challenging lesions with high subtotal resection rates. Suprasellar AP distance, retrosellar extension, and higher Zurich Score seem to be significant predictors of degree of resection in these tumors. Improving the intraoperative ability to distinguish tumor from a normal tissue might further decrease the number of unexpected residuals.</description><identifier>ISSN: 0001-6268</identifier><identifier>EISSN: 0942-0940</identifier><identifier>DOI: 10.1007/s00701-020-04497-1</identifier><identifier>PMID: 32700080</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Adenoma - pathology ; Adenoma - surgery ; Adult ; Aged ; Aged, 80 and over ; Endoscopy ; Endoscopy - methods ; Female ; Humans ; Interventional Radiology ; Magnetic resonance imaging ; Male ; Margins of Excision ; Medicine ; Medicine & Public Health ; Middle Aged ; Minimally Invasive Surgery ; Neoplasm, Residual ; Neurology ; Neuroradiology ; Neurosurgery ; Neurosurgical Procedures - methods ; Original Article - Pituitaries ; Pituitaries ; Pituitary ; Pituitary Neoplasms - pathology ; Pituitary Neoplasms - surgery ; Retrospective Studies ; Risk factors ; Sphenoid Bone - surgery ; Surgery ; Surgical Orthopedics ; Treatment Outcome ; Tumors</subject><ispartof>Acta neurochirurgica, 2020-10, Vol.162 (10), p.2341-2351</ispartof><rights>Springer-Verlag GmbH Austria, part of Springer Nature 2020</rights><rights>Springer-Verlag GmbH Austria, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-8af1f32f03e364ae1089dcc9eaf126f533a52ed7fd61e8e970a6f7d84b1b3663</citedby><cites>FETCH-LOGICAL-c403t-8af1f32f03e364ae1089dcc9eaf126f533a52ed7fd61e8e970a6f7d84b1b3663</cites><orcidid>0000-0002-6015-6862</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32700080$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peto, Ivo</creatorcontrib><creatorcontrib>Abou-Al-Shaar, Hussam</creatorcontrib><creatorcontrib>White, Timothy G.</creatorcontrib><creatorcontrib>Abunimer, Abdullah M.</creatorcontrib><creatorcontrib>Kwan, Kevin</creatorcontrib><creatorcontrib>Zavadskiy, Gleb</creatorcontrib><creatorcontrib>Wagner, Katherine</creatorcontrib><creatorcontrib>Black, Karen</creatorcontrib><creatorcontrib>Eisenberg, Mark</creatorcontrib><creatorcontrib>Bruni, Margherita</creatorcontrib><creatorcontrib>Dehdashti, Amir R.</creatorcontrib><title>Sources of residuals after endoscopic transsphenoidal surgery for large and giant pituitary adenomas</title><title>Acta neurochirurgica</title><addtitle>Acta Neurochir</addtitle><addtitle>Acta Neurochir (Wien)</addtitle><description>Background
Giant and large pituitary adenomas (PA) constitute a specific subset of PAs, with gross total resection (GTR) rates frequently not exceeding 50%. Both an anatomical inaccessibility and an inadequate tumor visualization are thought to play a role. This study analyzes risk factors for postoperative residuals after endoscopic transsphenoidal pituitary surgery for large and giant pituitary adenomas.
Methods
A retrospective analysis of patients with giant and large PA operated between 2015 and 2018 was performed.
Results
Forty patients (13 females, 27 males) were included in the analysis (30 large and 10 giant PAs). The mean MRI follow-up time was 5.9 ± 6.54 months. Overall, GTR was achieved in 29 patients (72.5%), subtotal resection in 9 (22.5%), and the inconclusive result was in 2 (5%). Unexpected residuals represented 7 (77.7%) of all 9 residual tumors. The most frequent intraoperative factor associated with unexpected residual tumors was improper identification of residual tumor due to obstruction of view in 2 (28.5%) cases and inability to distinguish normal tissue from tumor in the other two (28.5%). Sub-analysis based on tumor size revealed that with large PAs, GTR was achieved in 25 (83.3%), STR in 4 (13.3%), and inconclusive in 1 (3.3%) patient. In patients with giant PAs, GTR was achieved in 4 (40%), STR in 5 (50%), and inconclusive in 1 (10%). Analysis of preoperative factors showed a significant association of residual tumors with larger suprasellar AP distance (
p
= 0.041), retrosellar extension (
p
= 0.007), and higher Zurich Score (
p
= 0.029).
Conclusion
Large and giant PAs are challenging lesions with high subtotal resection rates. Suprasellar AP distance, retrosellar extension, and higher Zurich Score seem to be significant predictors of degree of resection in these tumors. Improving the intraoperative ability to distinguish tumor from a normal tissue might further decrease the number of unexpected residuals.</description><subject>Adenoma - pathology</subject><subject>Adenoma - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Endoscopy</subject><subject>Endoscopy - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Interventional Radiology</subject><subject>Magnetic resonance imaging</subject><subject>Male</subject><subject>Margins of Excision</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Minimally Invasive Surgery</subject><subject>Neoplasm, Residual</subject><subject>Neurology</subject><subject>Neuroradiology</subject><subject>Neurosurgery</subject><subject>Neurosurgical Procedures - methods</subject><subject>Original Article - Pituitaries</subject><subject>Pituitaries</subject><subject>Pituitary</subject><subject>Pituitary Neoplasms - pathology</subject><subject>Pituitary Neoplasms - surgery</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Sphenoid Bone - surgery</subject><subject>Surgery</subject><subject>Surgical Orthopedics</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><issn>0001-6268</issn><issn>0942-0940</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kctO3TAQhi0EAgq8QBfIEptuUsaXOMmyQvQiHamLsrd84jENyolTT7Lo2zNwoJVYsBmPPd_8tucX4qOCzwqguSYOoCrQUIG1XVOpA3EKndUVBzjkHLjstGtPxAeiB97pxppjcWJ0w7UWTkX8ldfSI8mcZEEa4hpGkiEtWCROMVOf56GXSwkT0fwbpzzEMEpayz2WvzLlIsfAuQxTlPdDmBY5D8s6LIGrITK_C3QujhLL4sXLeibuvt7e3XyvNj-__bj5sql6C2ap2pBUMjqBQeNsQAVtF_u-Qz7XLtXGhFpjbFJ0ClvsGgguNbG1W7U1zpkz8WkvO5f8Z0Va_G6gHscxTJhX8tpqV5u6VpbRqzfoA89h4sd5XWvdOWdV8y5lrTKtaw0wpfdUXzJRweTnMuz4_16BfzLK743ybJR_Nsorbrp8kV63O4z_Wl6dYcDsAeLSxMP-f_c7so9UKZ4-</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Peto, Ivo</creator><creator>Abou-Al-Shaar, Hussam</creator><creator>White, Timothy G.</creator><creator>Abunimer, Abdullah M.</creator><creator>Kwan, Kevin</creator><creator>Zavadskiy, Gleb</creator><creator>Wagner, Katherine</creator><creator>Black, Karen</creator><creator>Eisenberg, Mark</creator><creator>Bruni, Margherita</creator><creator>Dehdashti, Amir R.</creator><general>Springer Vienna</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6015-6862</orcidid></search><sort><creationdate>20201001</creationdate><title>Sources of residuals after endoscopic transsphenoidal surgery for large and giant pituitary adenomas</title><author>Peto, Ivo ; Abou-Al-Shaar, Hussam ; White, Timothy G. ; Abunimer, Abdullah M. ; Kwan, Kevin ; Zavadskiy, Gleb ; Wagner, Katherine ; Black, Karen ; Eisenberg, Mark ; Bruni, Margherita ; Dehdashti, Amir R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-8af1f32f03e364ae1089dcc9eaf126f533a52ed7fd61e8e970a6f7d84b1b3663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenoma - pathology</topic><topic>Adenoma - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Endoscopy</topic><topic>Endoscopy - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Interventional Radiology</topic><topic>Magnetic resonance imaging</topic><topic>Male</topic><topic>Margins of Excision</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Minimally Invasive Surgery</topic><topic>Neoplasm, Residual</topic><topic>Neurology</topic><topic>Neuroradiology</topic><topic>Neurosurgery</topic><topic>Neurosurgical Procedures - methods</topic><topic>Original Article - Pituitaries</topic><topic>Pituitaries</topic><topic>Pituitary</topic><topic>Pituitary Neoplasms - pathology</topic><topic>Pituitary Neoplasms - surgery</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Sphenoid Bone - surgery</topic><topic>Surgery</topic><topic>Surgical Orthopedics</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peto, Ivo</creatorcontrib><creatorcontrib>Abou-Al-Shaar, Hussam</creatorcontrib><creatorcontrib>White, Timothy G.</creatorcontrib><creatorcontrib>Abunimer, Abdullah M.</creatorcontrib><creatorcontrib>Kwan, Kevin</creatorcontrib><creatorcontrib>Zavadskiy, Gleb</creatorcontrib><creatorcontrib>Wagner, Katherine</creatorcontrib><creatorcontrib>Black, Karen</creatorcontrib><creatorcontrib>Eisenberg, Mark</creatorcontrib><creatorcontrib>Bruni, Margherita</creatorcontrib><creatorcontrib>Dehdashti, Amir R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>PHMC-Proquest健康医学期刊库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Acta neurochirurgica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peto, Ivo</au><au>Abou-Al-Shaar, Hussam</au><au>White, Timothy G.</au><au>Abunimer, Abdullah M.</au><au>Kwan, Kevin</au><au>Zavadskiy, Gleb</au><au>Wagner, Katherine</au><au>Black, Karen</au><au>Eisenberg, Mark</au><au>Bruni, Margherita</au><au>Dehdashti, Amir R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sources of residuals after endoscopic transsphenoidal surgery for large and giant pituitary adenomas</atitle><jtitle>Acta neurochirurgica</jtitle><stitle>Acta Neurochir</stitle><addtitle>Acta Neurochir (Wien)</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>162</volume><issue>10</issue><spage>2341</spage><epage>2351</epage><pages>2341-2351</pages><issn>0001-6268</issn><eissn>0942-0940</eissn><abstract>Background
Giant and large pituitary adenomas (PA) constitute a specific subset of PAs, with gross total resection (GTR) rates frequently not exceeding 50%. Both an anatomical inaccessibility and an inadequate tumor visualization are thought to play a role. This study analyzes risk factors for postoperative residuals after endoscopic transsphenoidal pituitary surgery for large and giant pituitary adenomas.
Methods
A retrospective analysis of patients with giant and large PA operated between 2015 and 2018 was performed.
Results
Forty patients (13 females, 27 males) were included in the analysis (30 large and 10 giant PAs). The mean MRI follow-up time was 5.9 ± 6.54 months. Overall, GTR was achieved in 29 patients (72.5%), subtotal resection in 9 (22.5%), and the inconclusive result was in 2 (5%). Unexpected residuals represented 7 (77.7%) of all 9 residual tumors. The most frequent intraoperative factor associated with unexpected residual tumors was improper identification of residual tumor due to obstruction of view in 2 (28.5%) cases and inability to distinguish normal tissue from tumor in the other two (28.5%). Sub-analysis based on tumor size revealed that with large PAs, GTR was achieved in 25 (83.3%), STR in 4 (13.3%), and inconclusive in 1 (3.3%) patient. In patients with giant PAs, GTR was achieved in 4 (40%), STR in 5 (50%), and inconclusive in 1 (10%). Analysis of preoperative factors showed a significant association of residual tumors with larger suprasellar AP distance (
p
= 0.041), retrosellar extension (
p
= 0.007), and higher Zurich Score (
p
= 0.029).
Conclusion
Large and giant PAs are challenging lesions with high subtotal resection rates. Suprasellar AP distance, retrosellar extension, and higher Zurich Score seem to be significant predictors of degree of resection in these tumors. Improving the intraoperative ability to distinguish tumor from a normal tissue might further decrease the number of unexpected residuals.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>32700080</pmid><doi>10.1007/s00701-020-04497-1</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-6015-6862</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0001-6268 |
ispartof | Acta neurochirurgica, 2020-10, Vol.162 (10), p.2341-2351 |
issn | 0001-6268 0942-0940 |
language | eng |
recordid | cdi_proquest_miscellaneous_2426535514 |
source | Springer Nature |
subjects | Adenoma - pathology Adenoma - surgery Adult Aged Aged, 80 and over Endoscopy Endoscopy - methods Female Humans Interventional Radiology Magnetic resonance imaging Male Margins of Excision Medicine Medicine & Public Health Middle Aged Minimally Invasive Surgery Neoplasm, Residual Neurology Neuroradiology Neurosurgery Neurosurgical Procedures - methods Original Article - Pituitaries Pituitaries Pituitary Pituitary Neoplasms - pathology Pituitary Neoplasms - surgery Retrospective Studies Risk factors Sphenoid Bone - surgery Surgery Surgical Orthopedics Treatment Outcome Tumors |
title | Sources of residuals after endoscopic transsphenoidal surgery for large and giant pituitary adenomas |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T00%3A30%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sources%20of%20residuals%20after%20endoscopic%20transsphenoidal%20surgery%20for%20large%20and%20giant%20pituitary%20adenomas&rft.jtitle=Acta%20neurochirurgica&rft.au=Peto,%20Ivo&rft.date=2020-10-01&rft.volume=162&rft.issue=10&rft.spage=2341&rft.epage=2351&rft.pages=2341-2351&rft.issn=0001-6268&rft.eissn=0942-0940&rft_id=info:doi/10.1007/s00701-020-04497-1&rft_dat=%3Cproquest_cross%3E2522966417%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c403t-8af1f32f03e364ae1089dcc9eaf126f533a52ed7fd61e8e970a6f7d84b1b3663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2441386830&rft_id=info:pmid/32700080&rfr_iscdi=true |